应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01858 春立医疗
交易中 09-24 14:29:47
7.780
-0.105
-1.33%
最高
7.855
最低
7.715
成交量
19.63万
今开
7.855
昨收
7.885
日振幅
1.78%
总市值
29.88亿
流通市值
7.40亿
总股本
3.84亿
成交额
152.37万
换手率
0.21%
流通股本
9,514万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
Morgan Stanley增持春立医疗(01858.HK)约21.61万股 每股作价约7.49港元
智通财经 · 09-23 19:11
Morgan Stanley增持春立医疗(01858.HK)约21.61万股 每股作价约7.49港元
春立医疗:摩根士丹利增持,好仓比例升至5.0%
港股披露 · 09-23 17:17
春立医疗:摩根士丹利增持,好仓比例升至5.0%
春立医疗(688236)披露公司秘书逝世公告,9月14日股价上涨1.65%
证券之星 · 09-14
春立医疗(688236)披露公司秘书逝世公告,9月14日股价上涨1.65%
股市必读:春立医疗新发布《H股市场公告》
证券之星 · 09-14
股市必读:春立医疗新发布《H股市场公告》
每周股票复盘:春立医疗(688236)将召开2026年半年度业绩说明会
证券之星 · 09-13
每周股票复盘:春立医疗(688236)将召开2026年半年度业绩说明会
春立医疗获得发明专利授权:“一种可调节肌腱韧带测量器”
证券之星 · 09-12
春立医疗获得发明专利授权:“一种可调节肌腱韧带测量器”
春立医疗(01858.HK):公司秘书、授权代表及法律程序文件代理人叶沛森逝世
智通财经 · 09-11
春立医疗(01858.HK):公司秘书、授权代表及法律程序文件代理人叶沛森逝世
春立医疗(01858)公司秘书兼授权代表叶沛森逝世
公告速递 · 09-11
春立医疗(01858)公司秘书兼授权代表叶沛森逝世
春立医疗将于9月17日召开2026年半年度业绩说明会
公告速递 · 09-10
春立医疗将于9月17日召开2026年半年度业绩说明会
春立医疗(688236)披露召开2026年半年度业绩说明会公告,9月10日股价下跌1.3%
证券之星 · 09-10
春立医疗(688236)披露召开2026年半年度业绩说明会公告,9月10日股价下跌1.3%
每周股票复盘:春立医疗(688236)H股及A股股本无变动
证券之星 · 09-06
每周股票复盘:春立医疗(688236)H股及A股股本无变动
股市必读:春立医疗新发布《H股市场公告》
证券之星 · 09-03
股市必读:春立医疗新发布《H股市场公告》
春立医疗(688236)披露截至2026年8月31日证券变动月报表,9月2日股价下跌1.83%
证券之星 · 09-02
春立医疗(688236)披露截至2026年8月31日证券变动月报表,9月2日股价下跌1.83%
春立医疗8月股份变动月报:股本保持稳定
公告速递 · 09-02
春立医疗8月股份变动月报:股本保持稳定
春立医疗(688236)披露2026年半年度报告,8月31日股价下跌2.92%
证券之星 · 08-31
春立医疗(688236)披露2026年半年度报告,8月31日股价下跌2.92%
春立医疗(01858)发布“提质增效重回报”半年评估:上半年派息逾5700万元、新增16项发明专利
公告速递 · 08-31
春立医疗(01858)发布“提质增效重回报”半年评估:上半年派息逾5700万元、新增16项发明专利
春立医疗(01858)拟动用不超过6亿元闲置募资进行现金管理
公告速递 · 08-31
春立医疗(01858)拟动用不超过6亿元闲置募资进行现金管理
春立医疗(01858)拟以22亿元闲置资金开展一年期保本型现金管理
公告速递 · 08-31
春立医疗(01858)拟以22亿元闲置资金开展一年期保本型现金管理
春立医疗:拟使用不超6.00亿元部分闲置募集资金和不超16.00亿元闲置自有资金进行现金管理
南方财经网 · 08-31
春立医疗:拟使用不超6.00亿元部分闲置募集资金和不超16.00亿元闲置自有资金进行现金管理
春立医疗披露2026年半年报:营收4.17亿元 同比降14.46%,净利增4.79%拟派息每10股1.30元
公告速递 · 08-31
春立医疗披露2026年半年报:营收4.17亿元 同比降14.46%,净利增4.79%拟派息每10股1.30元
加载更多
公司概况
公司名称:
春立医疗
所属市场:
SEHK
上市日期:
--
主营业务:
北京市春立正达医疗器械股份有限公司是一家主要从事植入性骨科医疗器械研发、生产及销售业务的中国公司。该公司主要产品包括关节假体产品、脊柱类植入产品、创伤类产品、运动医学类产品、富血小板血浆(PRP)产品、口腔类产品、手术机器人产品。关节假体产品涵盖髋、膝、肩、肘四大人体关节。该公司产品销往国内外市场。
发行价格:
--
{"stockData":{"symbol":"01858","market":"HK","secType":"STK","nameCN":"春立医疗","latestPrice":7.78,"timestamp":1790230728659,"preClose":7.885,"halted":0,"volume":196250,"delay":0,"changeRate":-0.013316423589093157,"floatShares":95140500,"shares":384000000,"eps":0.829330070741769,"marketStatus":"交易中","change":-0.105,"latestTime":"09-24 14:29:47","open":7.855,"high":7.855,"low":7.715,"amount":1523702,"amplitude":0.017755,"askPrice":7.78,"askSize":1250,"bidPrice":7.77,"bidSize":2000,"shortable":0,"etf":0,"ttmEps":0.8411976672470316,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1790237400000},"marketStatusCode":2,"adr":0,"listingDate":1426003200000,"exchange":"SEHK","adjPreClose":7.885,"dividendRate":0.052186,"openAndCloseTimeList":[[1790213400000,1790222400000],[1790226000000,1790236800000]],"volumeRatio":0.231968,"lotSize":250,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688236","market":"SH","secType":"STK","nameCN":"春立医疗","latestPrice":14.15,"timestamp":1790231384000,"preClose":14.58,"halted":0,"volume":1879100,"delay":0,"premium":"-52.93"}},"requestUrl":"/m/hq/s/01858","defaultTab":"news","newsList":[{"id":"2669488637","title":"Morgan Stanley增持春立医疗(01858.HK)约21.61万股 每股作价约7.49港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669488637","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669488637?lang=zh_cn&edition=full","pubTime":"2026-09-23 19:11","pubTimestamp":1790161880,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1100","01858","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146871581","title":"春立医疗:摩根士丹利增持,好仓比例升至5.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=1146871581","media":"港股披露","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146871581?lang=zh_cn&edition=full","pubTime":"2026-09-23 17:17","pubTimestamp":1790155066,"startTime":"0","endTime":"0","summary":"摩根士丹利于2026年9月18日在联交所场内以每股均价7.4942港元买入春立医疗股份21.61万股,涉资约161.97万港元,属场内主动交易,即在二级市场直接买卖股份。摩根士丹利此次增持前持有春立医疗好仓454.30万股,占比4.77%;增持后持股量为475.91万股,好仓比例升至5.0%。原文链接:Hong Kong Exchanges and Clearing Limited","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f7700173111443e192ac74957e46cb69","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667451652","title":"春立医疗(688236)披露公司秘书逝世公告,9月14日股价上涨1.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667451652","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667451652?lang=zh_cn&edition=full","pubTime":"2026-09-14 17:50","pubTimestamp":1789379428,"startTime":"0","endTime":"0","summary":"截至2026年9月14日收盘,春立医疗报收于13.59元,较前一交易日上涨1.65%,最新总市值为52.13亿元。该股当日开盘13.26元,最高13.7元,最低13.21元,成交额达1914.88万元,换手率为0.49%。公告显示,叶先生任职期间勤勉尽责,公司对其超过十年的贡献表示感谢,并向其家属致以慰问。叶先生逝世后,公司将暂无公司秘书及法律程序文件代理人,仅剩一名授权代表,不符合上市规则相关条款要求。董事会将尽快物色合适人选填补空缺,并适时另行公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400024065.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688236","BK1100","01858","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667263333","title":"股市必读:春立医疗新发布《H股市场公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667263333","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667263333?lang=zh_cn&edition=full","pubTime":"2026-09-14 04:31","pubTimestamp":1789331471,"startTime":"0","endTime":"0","summary":"公司公告汇总H股市场公告北京市春立正达医疗器械股份有限公司董事会宣布,公司秘书、授权代表及法律程序文件代理人叶沛森先生已于2026年9月10日逝世。叶先生任职期间勤勉尽责,公司对其超过十年的贡献表示感谢,并向其家属致以慰问。叶先生逝世后,公司将暂无公司秘书及法律程序文件代理人,仅剩一名授权代表,不符合上市规则相关条款要求。董事会将尽快物色合适人选填补空缺,并适时另行公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400001961.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688236","BK1585","01858","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667078500","title":"每周股票复盘:春立医疗(688236)将召开2026年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2667078500","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667078500?lang=zh_cn&edition=full","pubTime":"2026-09-13 04:03","pubTimestamp":1789243394,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘,春立医疗报收于13.37元,较上周的14.2元下跌5.85%。公司公告汇总北京市春立正达医疗器械股份有限公司将于2026年9月17日11:00-12:00通过上证路演中心网络互动方式召开2026年半年度业绩说明会,介绍公司经营成果及财务状况。北京市春立正达医疗器械股份有限公司董事会沉痛宣布,公司秘书、授权代表及法律程序文件代理人叶沛森先生已于2026年9月10日逝世。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300001574.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK1585","BK1100","01858","688236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666711915","title":"春立医疗获得发明专利授权:“一种可调节肌腱韧带测量器”","url":"https://stock-news.laohu8.com/highlight/detail?id=2666711915","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666711915?lang=zh_cn&edition=full","pubTime":"2026-09-12 03:48","pubTimestamp":1789156122,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示春立医疗新获得一项发明专利授权,专利名为“一种可调节肌腱韧带测量器”,专利申请号为CN202311415876.8,授权日为2026年9月11日。通过天眼查大数据分析,北京市春立正达医疗器械股份有限公司共对外投资了8家企业,参与招投标项目533次;财产线索方面有商标信息13条,专利信息1187条,著作权信息16条;此外企业还拥有行政许可174个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091200004514.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1100","BK1585","BK0251","01858","688236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666528967","title":"春立医疗(01858.HK):公司秘书、授权代表及法律程序文件代理人叶沛森逝世","url":"https://stock-news.laohu8.com/highlight/detail?id=2666528967","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666528967?lang=zh_cn&edition=full","pubTime":"2026-09-11 17:30","pubTimestamp":1789119003,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1585","01858","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114001815","title":"春立医疗(01858)公司秘书兼授权代表叶沛森逝世","url":"https://stock-news.laohu8.com/highlight/detail?id=1114001815","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114001815?lang=zh_cn&edition=full","pubTime":"2026-09-11 17:25","pubTimestamp":1789118735,"startTime":"0","endTime":"0","summary":"北京市春立正达医疗器械股份有限公司9月11日发布公告称,公司秘书、根据香港联交所《证券上市规则》第3.05条委任的授权代表及根据香港法例第622章公司条例第16部和上市规则第19A.13条担任法律程序文件代理人的叶沛森先生已于2026年9月10日逝世。董事会对叶沛森先生十余年来对公司的贡献表示衷心感谢,并向其家属致以深切慰问。公司表示,将在切实可行的情况下尽快物色合适人选填补相关职务空缺,并于适当时候另行公告。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149463470","title":"春立医疗将于9月17日召开2026年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=1149463470","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149463470?lang=zh_cn&edition=full","pubTime":"2026-09-10 20:05","pubTimestamp":1789041953,"startTime":"0","endTime":"0","summary":"\\n\\n公告显示,投资者可于2026年09月10日(星期四)至2026年09月16日(星期三)16:00前,登录上证路演中心“提问预征集”栏目或通过公司邮箱ir@clzd.com进行提问。公司将在说明会上针对投资者普遍关注的问题进行集中答复。说明会结束后,投资者可通过上证路演中心查看会议情况及主要内容。\\n\\n春立医疗已于2026年08月29日披露2026年半年度报告。公司称,本次说明会旨在帮助投资者更全面了解公司2026年半年度的经营成果与财务状况。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666562264","title":"春立医疗(688236)披露召开2026年半年度业绩说明会公告,9月10日股价下跌1.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666562264","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666562264?lang=zh_cn&edition=full","pubTime":"2026-09-10 18:18","pubTimestamp":1789035496,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘,春立医疗报收于13.71元,较前一交易日下跌1.3%,最新总市值为52.59亿元。该股当日开盘13.91元,最高13.91元,最低13.7元,成交额达1685.91万元,换手率为0.42%。公告显示,北京市春立正达医疗器械股份有限公司将于2026年9月17日11:00-12:00通过上证路演中心网络互动方式召开2026年半年度业绩说明会,介绍公司经营成果及财务状况。投资者可于2026年9月10日至9月16日16:00前通过上证路演中心网站或公司邮箱ir@clzd.com提交问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000035221.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688236","BK0251","BK1585","BK1100","01858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665366688","title":"每周股票复盘:春立医疗(688236)H股及A股股本无变动","url":"https://stock-news.laohu8.com/highlight/detail?id=2665366688","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665366688?lang=zh_cn&edition=full","pubTime":"2026-09-06 03:23","pubTimestamp":1788636190,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘,春立医疗报收于14.2元,较上周的14.36元下跌1.11%。春立医疗当前最新总市值54.47亿元,在医疗器械板块市值排名69/129,在两市A股市值排名2991/5214。公司公告汇总H股市场公告北京市春立正达医疗器械股份有限公司提交截至2026年8月31日的证券变动月报表。公司H股和A股的法定/注册股本及已发行股份在本月无变动。H股类别已发行股份为95,140,500股,A股类别为288,428,000股,其中库存股1,376,851股。公司确认H股公众持股量符合上市规则要求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600001134.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["82846","BK1585","399300","688236","BK1100","03130","01858","02846","07233","159982","BK0251","BK1147","83130","03188","02827","83188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664084519","title":"股市必读:春立医疗新发布《H股市场公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664084519","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664084519?lang=zh_cn&edition=full","pubTime":"2026-09-03 02:13","pubTimestamp":1788372789,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘,春立医疗报收于13.98元,下跌1.83%,换手率0.96%,成交量2.78万手,成交额3911.21万元。公司公告汇总:截至2026年8月31日,春立医疗H股与A股已发行股份均无变动,H股公众持股量持续符合香港联交所上市规则要求。公司H股和A股的法定/注册股本及已发行股份在本月无变动。H股已发行股份为95,140,500股,A股已发行股份为288,428,000股,其中库存股1,376,851股。本月无股份增减变动,亦无权证、可换股票据或香港预托证券相关事项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300001987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1585","BK0251","01858","688236","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664889096","title":"春立医疗(688236)披露截至2026年8月31日证券变动月报表,9月2日股价下跌1.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664889096","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664889096?lang=zh_cn&edition=full","pubTime":"2026-09-02 17:27","pubTimestamp":1788341271,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘,春立医疗报收于13.98元,较前一交易日下跌1.83%,最新总市值为53.62亿元。该股当日开盘14.19元,最高14.24元,最低13.95元,成交额达3911.21万元,换手率为0.96%。近日,北京市春立正达医疗器械股份有限公司提交截至2026年8月31日的证券变动月报表。H股类别已发行股份为95,140,500股,A股类别为288,428,000股,其中库存股1,376,851股。公司确认H股公众持股量符合上市规则要求。本月无股份增减变动,亦无权证、可换股票据或香港预托证券相关事项。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200030986.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1100","688236","161027","BK1585","01858","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171536243","title":"春立医疗8月股份变动月报:股本保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1171536243","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1171536243?lang=zh_cn&edition=full","pubTime":"2026-09-02 14:51","pubTimestamp":1788331898,"startTime":"0","endTime":"0","summary":"北京市春立正达医疗器械股份有限公司于2026年9月2日披露了截至2026年8月31日的股份变动月报表。根据公告,春立医疗本月法定注册股本总额为人民币383,568,500元,保持不变。其中,H股法定注册股份数目为95,140,500股,每股面值人民币1元;A股法定注册股份数目为288,428,000股,每股面值人民币1元,分别与上月底持平。据公告披露,本次月报由公司秘书叶沛森签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663728140","title":"春立医疗(688236)披露2026年半年度报告,8月31日股价下跌2.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663728140","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663728140?lang=zh_cn&edition=full","pubTime":"2026-08-31 18:30","pubTimestamp":1788172243,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘,春立医疗报收于13.94元,较前一交易日下跌2.92%,最新总市值为53.47亿元。该股当日开盘14.37元,最高14.37元,最低13.65元,成交额达4822.1万元,换手率为1.2%。近日,春立医疗披露《2026年半年度报告》。公告显示,公司2026年上半年实现营业收入417,104,217.14元,同比下降14.46%;归属于上市公司股东的净利润为119,957,018.06元,同比增长4.79%;扣除非经常性损益后的净利润为114,147,628.46元,同比增长7.50%。经营活动产生的现金流量净额为34,322,013.72元,同比减少75.74%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100028492.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688236","01858","BK1585","BK1100","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163286253","title":"春立医疗(01858)发布“提质增效重回报”半年评估:上半年派息逾5700万元、新增16项发明专利","url":"https://stock-news.laohu8.com/highlight/detail?id=1163286253","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1163286253?lang=zh_cn&edition=full","pubTime":"2026-08-31 09:50","pubTimestamp":1788141055,"startTime":"0","endTime":"0","summary":"8月31日,北京市春立正达医疗器械股份有限公司在港交所公告披露《2026年度“提质增效重回报”专项行动方案的半年度评估报告》,总结了2026年上半年在主业聚焦、研发创新、公司治理与股东回报等方面的进展与成效。春立医疗表示,将继续评估“提质增效重回报”专项行动执行情况,及时披露相关进展,并在保持经营稳健的同时,持续提升投资者回报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181308486","title":"春立医疗(01858)拟动用不超过6亿元闲置募资进行现金管理","url":"https://stock-news.laohu8.com/highlight/detail?id=1181308486","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181308486?lang=zh_cn&edition=full","pubTime":"2026-08-31 09:50","pubTimestamp":1788141054,"startTime":"0","endTime":"0","summary":"2026年8月31日,北京市春立正达医疗器械股份有限公司公告称,公司董事会已于2026年8月28日审议通过议案,同意在12个月内使用最高不超过6亿元的部分闲置募集资金开展现金管理,投资于结构性存款、定期存款、通知存款及大额存单等保本型产品,相关资金可在额度内滚动使用。春立医疗表示,本次现金管理在不影响募投项目实施及日常经营的前提下进行,所得收益将优先补足募投项目资金缺口,并于产品到期后归还募集资金专户。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103105977","title":"春立医疗(01858)拟以22亿元闲置资金开展一年期保本型现金管理","url":"https://stock-news.laohu8.com/highlight/detail?id=1103105977","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103105977?lang=zh_cn&edition=full","pubTime":"2026-08-31 09:50","pubTimestamp":1788141051,"startTime":"0","endTime":"0","summary":"北京,2026年8月31日消息,春立医疗 公告称,公司已于2026年8月28日召开的第六届董事会第二次会议审议通过《关于使用部分闲置募集资金和自有资金进行现金管理的议案》,计划使用总额不超过22亿元的闲置资金进行为期12个月的现金管理,其中包括不超过6亿元的闲置募集资金及不超过16亿元的自有资金。此前,公司于2025年8月29日曾获批在12个月内使用不超过7亿元闲置募集资金及14亿元自有资金进行现金管理。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01858"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663263350","title":"春立医疗:拟使用不超6.00亿元部分闲置募集资金和不超16.00亿元闲置自有资金进行现金管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2663263350","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663263350?lang=zh_cn&edition=full","pubTime":"2026-08-31 09:47","pubTimestamp":1788140820,"startTime":"0","endTime":"0","summary":"南财智讯8月31日电,春立医疗(01858.HK)公告,公司于2026年8月28日召开第六届董事会第二次会议,审议通过了《关于使用部分闲置募集资金和自有资金进行现金管理的议案》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608313859766268.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608313859766268.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0251","BK1100","MMKT","688236","IQMM","01858","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144180665","title":"春立医疗披露2026年半年报:营收4.17亿元 同比降14.46%,净利增4.79%拟派息每10股1.30元","url":"https://stock-news.laohu8.com/highlight/detail?id=1144180665","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144180665?lang=zh_cn&edition=full","pubTime":"2026-08-31 09:46","pubTimestamp":1788140768,"startTime":"0","endTime":"0","summary":"2026年8月31日,北京市春立正达医疗器械股份有限公司发布2026年半年度报告。报告期内,公司实现营业收入4.17亿元,同比下降14.46%;归属于母公司股东的净利润为1.20亿元,同比增长4.79%;扣非后净利润1.14亿元,同比增长7.50%。期内经营活动产生的现金流量净额为0.34亿元,同比下降75.74%。截至2026年6月30日,公司总资产35.91亿元,较去年末减少1.91%;归属于母公司所有者权益30.48亿元,较去年末增长2.10%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01858"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.clzd.com","stockEarnings":[{"period":"1week","weight":0.0038},{"period":"1month","weight":-0.0831},{"period":"3month","weight":-0.0702},{"period":"6month","weight":-0.3677},{"period":"1year","weight":-0.4738},{"period":"ytd","weight":-0.4596}],"compareEarnings":[{"period":"1week","weight":0.0049},{"period":"1month","weight":-0.0268},{"period":"3month","weight":0.0761},{"period":"6month","weight":-0.0047},{"period":"1year","weight":-0.0507},{"period":"ytd","weight":-0.0311}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京市春立正达医疗器械股份有限公司是一家主要从事植入性骨科医疗器械研发、生产及销售业务的中国公司。该公司主要产品包括关节假体产品、脊柱类植入产品、创伤类产品、运动医学类产品、富血小板血浆(PRP)产品、口腔类产品、手术机器人产品。关节假体产品涵盖髋、膝、肩、肘四大人体关节。该公司产品销往国内外市场。","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":0.005345},{"month":2,"riseRate":0.6,"avgChangeRate":0.051373},{"month":3,"riseRate":0.545455,"avgChangeRate":0.025532},{"month":4,"riseRate":0.583333,"avgChangeRate":0.047388},{"month":5,"riseRate":0.5,"avgChangeRate":-0.001918},{"month":6,"riseRate":0.5,"avgChangeRate":0.041759},{"month":7,"riseRate":0.416667,"avgChangeRate":0.012507},{"month":8,"riseRate":0.25,"avgChangeRate":-0.004797},{"month":9,"riseRate":0.583333,"avgChangeRate":0.043124},{"month":10,"riseRate":0.727273,"avgChangeRate":0.039745},{"month":11,"riseRate":0.545455,"avgChangeRate":-0.020287},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.020574}],"exchange":"SEHK","name":"春立医疗","nameEN":"CHUNLI MEDICAL"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"春立医疗(01858)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供春立医疗(01858)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"春立医疗,01858,春立医疗股票,春立医疗股票老虎,春立医疗股票老虎国际,春立医疗行情,春立医疗股票行情,春立医疗股价,春立医疗股市,春立医疗股票价格,春立医疗股票交易,春立医疗股票购买,春立医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"春立医疗(01858)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供春立医疗(01858)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}